Featured News
news cover
Fulcrum Therapeutics Announces Results from the 12 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease
11 hours ago
news cover
FDA Provides Trethera Clearance to Initiate TRE-515 Clinical Trial in Healthy Volunteers to Study Food Effect and Biomarkers
10 hours ago
news cover
Immutep to Present Pivotal TACTI-004 Trial in Progress Poster at the 2025 World Conference on Lung Cancer
20 hours ago
news cover
Cognition Therapeutics Presents Data at AAIC Highlighting Broad Neurological Impact of Zervimesine (CT1812) in Dementia with Lewy Bodies and Alzheimer’s Disease
20 hours ago
View more
Global Express
3 hours ago
BioLab Holdings, Inc. Launches Its Largest Clinical Trial to Date Evaluating Human Placental Membrane Products
Clinical Study
4 hours ago
FDA approves Alhemo® as once-daily prophylactic treatment to prevent or reduce the frequency of bleeding episodes for adults and children 12 years of age and older with hemophilia A or B (HA/HB) without inhibitors
Phase 3Clinical ResultDrug Approval
4 hours ago
Novartis twice-yearly* Leqvio® (inclisiran) receives FDA approval for new indication enabling first-line use
Drug ApprovalLicense out/inAHA
5 hours ago
Avanos Announces Divestiture of Hyaluronic Acid Product Line to Channel-Markers Medical
Acquisition
5 hours ago
Human Longevity Extends $1M Cancer Pledge to Lung Cancer--Betting Big on AI-Driven Early Detection
View more
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Hot reports
May 2025 Patent Highlights
May 2025 Patent Highlights
Patsnap Synapse
JMC Annotation Spotlight: Analysis of Breakthrough Therapeutics
JMC Annotation Spotlight: Analysis of Breakthrough Therapeutics
Patsnap Synapse
Global Drug R&D Express (February 2025)
Global Drug R&D Express (February 2025)
PatSnap Synapse
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.